Filing Details

Accession Number:
0001127602-13-025752
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-08-21 16:55:44
Reporting Period:
2013-08-19
Filing Date:
2013-08-21
Accepted Time:
2013-08-21 16:55:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
820096 Perrigo Co PRGO Pharmaceutical Preparations (2834) 382799573
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1267878 W Todd Kingma C/O Perrigo Company
515 Eastern Avenue
Allegan MI 49010
Executive Vp, General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-08-19 4,106 $118.74 21,171 No 4 M Direct
Common Stock Disposition 2013-08-19 1,298 $118.74 19,873 No 4 F Direct
Common Stock Disposition 2013-08-20 2,500 $118.55 17,373 No 4 S Direct
Common Stock Disposition 2013-08-20 308 $119.23 17,065 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2013-08-19 4,106 $0.00 4,106 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2013-08-19 2013-08-19 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 961 Indirect By Trust
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on December 7, 2012. This 10b5-1 sales plan will expire on the close of business December 31, 2013.
  2. The price in column 4 is a weighted average. The prices actually received ranged from $118.17 to $119.13. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
  3. The price in column 4 is a weighted average. The prices actually received ranged from $119.22 to $119.40. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
  4. By Trust, of which the reporting person is the Trustee.
  5. Vesting of Restricted Stock Units granted on August 19, 2010.